País: Irlanda
Língua: inglês
Origem: HPRA (Health Products Regulatory Authority)
AVIAN INFECTIOUS BRONCHITIS VIRUS STRAIN MASSACHUSETTS 1263, AVIAN INFECTIOUS BRONCHITIS VIRUS STRAIN ARKANSAS 3168
Zoetis Ireland Limited
QI01AD07
AVIAN INFECTIOUS BRONCHITIS VIRUS STRAIN MASSACHUSETTS 1263, AVIAN INFECTIOUS BRONCHITIS VIRUS STRAIN ARKANSAS 3168
Powder for nebuliser solution
POM: Prescription Only Medicine as defined in relevant national legislation
Fowl - Chicken
avian infectious bronchitis virus
Immunological - Live Vaccine
Authorised
2013-12-09
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT POULVAC IBMM + ARK – Powder for nebuliser solution for broiler chickens. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Powder for nebuliser solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Broiler chickens. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of chickens to reduce the severity of upper respiratory tract infections caused by Massachusetts and 793/B/91-type strains of Avian Infectious Bronchitis virus. The onset of immunity is from three weeks post vaccination and lasts for six weeks post vaccination. Protection has also been demonstrated in the presence of maternally derived antibody. 4.3 CONTRAINDICATIONS Do not use in unhealthy birds. Do not re-vaccinate birds. Do not use during the laying period or in birds intended for laying or breeding. Spray vaccination should not be used if an intercurrent infection is suspected. Quantitative composition ACTIVE SUBSTANCES: GLOBAL AMOUNT PER DOSE Avian Infectious Bronchitis Virus 10 3.3 EID 50 * (Strain Massachusetts1263 and Strain Arkansas 3168) *EID 50 : Embryo infective dose 50% EXCIPIENTS: For a full list of excipients, see section 6.1. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _0_ _7_ _/_ _0_ _1_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _2_ _5_ _2_ _1_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Infectious Bronchitis virus Leia o documento completo